Tuesday, March 28, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Defense + Military

DoD Seeks Tuberculosis Disinfectant

by Global Biodefense Staff
July 21, 2015
DoD Seeks Tuberculosis Disinfectant

The U.S. Army Medical Research Acquisition Activity (USAMRAA), on behalf of the US Army Medical Research Institute of Infectious Diseases (USAMRIID), has issued a requirement for brand name or equal Pharmacal Quatricide TB Disinfectant.

The product is a phosphate free tuberculocidal spray disinfectant, effective as a Tuberculocide, Bactericide, Fungicide and virucide.

The selected contractor will supply 75-225 cases of TB disinfectant each month, for use by the Department of Defense medical community. The item is for disinfecting and deodorizing to include nonporous surfaces such as walls and floors.

USAMRIID plans to conduct a Technical Evaluation of samples provided from all interested offerors submitting a proposal.

Further details are available via Solicitation Number: W81XWH-15-T-0271. The response deadline is Aug. 7, 2015.

Tags: Tuberculosis

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
Load More

Latest News

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC